ClinConnect ClinConnect Logo
Search / Trial NCT04273438

Determining the Clinical Utility of Using Virtual Reality Headsets to Assess Visual Function in Those With Glaucoma.

Launched by QUEEN'S UNIVERSITY, BELFAST · Feb 13, 2020

Trial Information

Current as of August 02, 2025

Unknown status

Keywords

Perimetry Virtual Reality Visual Field Testing

ClinConnect Summary

Perimetry (or visual field testing) is a vision test used to evaluate a patient's peripheral vision. It involves a patient fixating on a central target and pressing a button when they see a spot of light in their peripheral vision. It is an important way of deciding whether Glaucoma is progressing or not. Next generation virtual reality (VR) technologies offer an exciting new way of conducting perimetry in either a clinical or home environment, allowing more affordable and more frequent monitoring of disease progression in glaucoma, and an easier and more comfortable experience for patients...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - Patients with a clinical diagnosis of glaucoma with repeatable defects on standard automated perimetry.
  • Exclusion Criteria:
  • Presence of other ocular disease which impacts vision such as age-related macular degeneration or diabetic retinopathy.
  • Any physical limitation that would make the participant unable to place their head in the head-rest to perform Humphrey Perimetry (Eg some patients with arthritic or neck problems are unable to use the headrests of ophthalmic devices).
  • Any cognitive impairment that would limit their ability to perform perimetry or a history of vertigo/dizziness.

About Queen's University, Belfast

Queen's University Belfast is a prestigious research institution located in Northern Ireland, renowned for its commitment to advancing knowledge and improving health outcomes through innovative clinical research. The university actively engages in a diverse range of clinical trials, focusing on translational medicine and interdisciplinary collaboration to address pressing health challenges. With a strong emphasis on ethical standards and patient safety, Queen's University Belfast leverages its state-of-the-art facilities and a team of experienced researchers to contribute to the development of new therapies and enhance the understanding of various medical conditions.

Locations

Belfast, Northern Ireland, United Kingdom

Patients applied

0 patients applied

Trial Officials

Ruth E Hogg, PhD

Principal Investigator

Queen's University, Belfast

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials